IntegriChain delivers the life science industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
To ensure you get the most out of your access and commercialization investment, IntegriChain provides a complete set of professional Advisory and Systems Integration Services designed to further your business and success.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Keep in touch with IntegrChain through our news and frequent events.
View all news & events
This paper has highlights the fact that invoice level validations alone cannot bring to light all the potential disputes in the Medicaid data. Without at least some level of use of CLD in your Medicaid process, manufacturers are prone to significant revenue leakage. Adding CLD to the Medicaid rebate adjudication process can be a huge benefit in identifying and resolving additional issues and thus allowing for more accurate payments and accruals. Despite these significant benefits, many manufacturers believe they simply do not have the time, resources, or expertise to effectively implement CLD.
Download now!